Literature DB >> 18841708

The "Microflora Hypothesis" of allergic disease.

Andrew Shreiner1, Gary B Huffnagle, Mairi C Noverr.   

Abstract

Predisposition to allergic disease is a complex function of an individual's genetic background and, as is the case with multi-gene traits, environmental factors have important phenotypic consequences. Over a span of decades, a dramatic increase in the prevalence of allergic disease in westernized populations suggests the occurrence of critical changes in environmental pressures. Recently, it has been shown that the microbiota (i.e. microflora) of allergic individuals differs from that of non-allergic ones and that differences are detectable prior to the onset of atopy, consistent with a possible causative role. Features of the westernized lifestyle that are known to alter the microbiota, such as antibiotics and diet, are also associated with allergy in humans. In this chapter, we discuss the "Microflora Hypothesis" for allergy which predicts that an "unhealthy" microbiota composition, now commonly found within westernized communities, contributes to the development of allergy and conversely, that restoring a "healthy" microbiota, perhaps through probiotic supplementation, may prevent the development of allergy or even treat existing disease. In testing this hypothesis, our laboratory has recently reported that mice can develop allergic airway responses if their microbiota is altered at the time of first allergen exposure.

Entities:  

Mesh:

Year:  2008        PMID: 18841708     DOI: 10.1007/978-0-387-09550-9_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  40 in total

Review 1.  Mucosal control of the intestinal microbial community.

Authors:  Sylvia Brugman; Edward E S Nieuwenhuis
Journal:  J Mol Med (Berl)       Date:  2010-06-04       Impact factor: 4.599

Review 2.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 3.  Mechanisms Underlying HIV-Associated Noninfectious Lung Disease.

Authors:  Rachel M Presti; Sonia C Flores; Brent E Palmer; Jeffrey J Atkinson; Catherine R Lesko; Bryan Lau; Andrew P Fontenot; Jesse Roman; John F McDyer; Homer L Twigg
Journal:  Chest       Date:  2017-04-17       Impact factor: 9.410

Review 4.  The human microbiome: from symbiosis to pathogenesis.

Authors:  Emiley A Eloe-Fadrosh; David A Rasko
Journal:  Annu Rev Med       Date:  2013       Impact factor: 13.739

Review 5.  Collateral damage: microbiota-derived metabolites and immune function in the antibiotic era.

Authors:  Christopher A Lopez; Dawn D Kingsbury; Eric M Velazquez; Andreas J Bäumler
Journal:  Cell Host Microbe       Date:  2014-08-13       Impact factor: 21.023

6.  Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice.

Authors:  Hannah Grazul; L Leann Kanda; David Gondek
Journal:  Gut Microbes       Date:  2016-03-10

Review 7.  The Role of the Microbiome in the Developmental Origins of Health and Disease.

Authors:  Leah T Stiemsma; Karin B Michels
Journal:  Pediatrics       Date:  2018-03-08       Impact factor: 7.124

Review 8.  The germ-organ theory of non-communicable diseases.

Authors:  Mariana X Byndloss; Andreas J Bäumler
Journal:  Nat Rev Microbiol       Date:  2018-01-08       Impact factor: 60.633

9.  Bacteria associated with immunoregulatory cells in mice.

Authors:  Laura L Presley; Bo Wei; Jonathan Braun; James Borneman
Journal:  Appl Environ Microbiol       Date:  2009-12-11       Impact factor: 4.792

Review 10.  The gastrointestinal microbiome: a malleable, third genome of mammals.

Authors:  Ian M Carroll; David W Threadgill; Deborah S Threadgill
Journal:  Mamm Genome       Date:  2009-07-21       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.